Norman E. Sharpless, et.al., The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis., Oncogene, 2004, 23

http://rdf.ncbi.nlm.nih.gov/pubmed/14724566

Norman E. Sharpless, et.al., The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis., Oncogene, 2004, 23

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Cdkn2a<tm1Nesh>
  http://metadb.riken.jp/db/mgi_rdf/MGI:2677722

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• abnormal cell physiology_Cdkn2a<tm1Rdp>/Cdkn2a<tm1Rdp>
  http://metadb.riken.jp/0005621I129SvC57BL6JFVBNSJLCdkn2atm1RdpCdkn2atm1RdpCdkn2atm1Rdp
• increased lung carcinoma incidence_Cdkn2a<tm1Nesh>/Cdkn2a<tm1Nesh>
  http://metadb.riken.jp/0008714I129S6SvEvTacFVBNCdkn2atm1NeshCdkn2atm1NeshCdkn2atm1Nesh
• increased sarcoma incidence_Cdkn2a<tm2.1Rdp>/Cdkn2a<tm2.1Rdp>
  http://metadb.riken.jp/0002032I129S6SvEvTacFVBNCdkn2atm21RdpCdkn2atm21RdpCdkn2atm21Rdp
• increased small lymphocytic lymphoma incidence_Cdkn2a<tm2.1Rdp>/Cdkn2a<tm2.1Rdp>
  http://metadb.riken.jp/0009319I129S6SvEvTacFVBNCdkn2atm21RdpCdkn2atm21RdpCdkn2atm21Rdp
• increased tumor incidence_Cdkn2a<tm1Rdp>/Cdkn2a<tm1Rdp>
  http://metadb.riken.jp/0002020I129SvC57BL6JFVBNSJLCdkn2atm1RdpCdkn2atm1RdpCdkn2atm1Rdp
• increased osteosarcoma incidence_Cdkn2a<tm2.1Rdp>/Cdkn2a<tm2.1Rdp>
  http://metadb.riken.jp/0003789I129S6SvEvTacFVBNCdkn2atm21RdpCdkn2atm21RdpCdkn2atm21Rdp
• increased sarcoma incidence_Cdkn2a<tm1Nesh>/Cdkn2a<tm1Nesh>
  http://metadb.riken.jp/0002032I129S6SvEvTacFVBNCdkn2atm1NeshCdkn2atm1NeshCdkn2atm1Nesh
• increased lymphoma incidence_Cdkn2a<tm1Rdp>/Cdkn2a<tm1Rdp>
  http://metadb.riken.jp/0012431I129SvC57BL6JFVBNSJLCdkn2atm1RdpCdkn2atm1RdpCdkn2atm1Rdp
• hindlimb paralysis_Cdkn2a<tm1Nesh>/Cdkn2a<tm1Nesh>
  http://metadb.riken.jp/0000755I129S6SvEvTacFVBNCdkn2atm1NeshCdkn2atm1NeshCdkn2atm1Nesh
• increased osteosarcoma incidence_Cdkn2a<tm1Nesh>/Cdkn2a<tm1Nesh>
  http://metadb.riken.jp/0003789I129S6SvEvTacFVBNCdkn2atm1NeshCdkn2atm1NeshCdkn2atm1Nesh
• increased tumor incidence_Cdkn2a<tm2.1Rdp>/Cdkn2a<tm2.1Rdp>
  http://metadb.riken.jp/0002020I129S6SvEvTacFVBNCdkn2atm21RdpCdkn2atm21RdpCdkn2atm21Rdp
• increased incidence of tumors by chemical induction_Cdkn2a<tm2.1Rdp>/Cdkn2a<tm2.1Rdp>
  http://metadb.riken.jp/0004499I129S6SvEvTacFVBNCdkn2atm21RdpCdkn2atm21RdpCdkn2atm21Rdp
• increased incidence of tumors by chemical induction_Cdkn2a<tm1Nesh>/Cdkn2a<tm1Nesh>
  http://metadb.riken.jp/0004499I129S6SvEvTacFVBNCdkn2atm1NeshCdkn2atm1NeshCdkn2atm1Nesh
• abnormal cell physiology_Cdkn2a<tm1Nesh>/Cdkn2a<tm1Nesh>
  http://metadb.riken.jp/0005621I129S6SvEvTacFVBNCdkn2atm1NeshCdkn2atm1NeshCdkn2atm1Nesh
• premature death_Cdkn2a<tm1Rdp>/Cdkn2a<tm1Rdp>
  http://metadb.riken.jp/0002083I129SvC57BL6JFVBNSJLCdkn2atm1RdpCdkn2atm1RdpCdkn2atm1Rdp
• increased tumor incidence_Cdkn2a<tm1Nesh>/Cdkn2a<tm1Nesh>
  http://metadb.riken.jp/0002020I129S6SvEvTacFVBNCdkn2atm1NeshCdkn2atm1NeshCdkn2atm1Nesh
• increased sarcoma incidence_Cdkn2a<tm1Rdp>/Cdkn2a<tm1Rdp>
  http://metadb.riken.jp/0002032I129SvC57BL6JFVBNSJLCdkn2atm1RdpCdkn2atm1RdpCdkn2atm1Rdp
• increased small lymphocytic lymphoma incidence_Cdkn2a<tm1Nesh>/Cdkn2a<tm1Nesh>
  http://metadb.riken.jp/0009319I129S6SvEvTacFVBNCdkn2atm1NeshCdkn2atm1NeshCdkn2atm1Nesh
• seizures_Cdkn2a<tm1Nesh>/Cdkn2a<tm1Nesh>
  http://metadb.riken.jp/0002064I129S6SvEvTacFVBNCdkn2atm1NeshCdkn2atm1NeshCdkn2atm1Nesh
• increased lymphoma incidence_Cdkn2a<tm2.1Rdp>/Cdkn2a<tm2.1Rdp>
  http://metadb.riken.jp/0012431I129S6SvEvTacFVBNCdkn2atm21RdpCdkn2atm21RdpCdkn2atm21Rdp

class

http://purl.org/net/cito/citesAsAuthority

• Cdkn2a<tm1Nesh>
  http://metadb.riken.jp/db/mgi_rdf/MGI:2677722